New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review

SIMPLE SUMMARY: Cancer therapy-related cardiac dysfunction (CTRCD) has been an urgent medical issue in patients that receive breast cancer therapies including anthracycline-based chemotherapies and/or targeted anti-HER2 therapies such as trastuzumab. Traditional biomarkers used as standard of care m...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandraki, Alexia, Papageorgiou, Elisavet, Zacharia, Marina, Keramida, Kalliopi, Papakonstantinou, Andri, Cipolla, Carlo M., Tsekoura, Dorothea, Naka, Katerina, Mazzocco, Ketti, Mauri, Davide, Tsiknakis, Manolis, Manikis, Georgios C., Marias, Kostas, Marcou, Yiola, Kakouri, Eleni, Konstantinou, Ifigenia, Daniel, Maria, Galazi, Myria, Kampouroglou, Effrosyni, Ribnikar, Domen, Brown, Cameron, Karanasiou, Georgia, Antoniades, Athos, Fotiadis, Dimitrios, Filippatos, Gerasimos, Constantinidou, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340234/
https://www.ncbi.nlm.nih.gov/pubmed/37444400
http://dx.doi.org/10.3390/cancers15133290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340234/
https://www.ncbi.nlm.nih.gov/pubmed/37444400
http://dx.doi.org/10.3390/cancers15133290

Ejemplares similares